CC
OCEA

Centiva Capital’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Centiva Capital’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,800
Closed -$21.7K – 2704
2024
Q2 		$21.7K Buy
+17,800
New +$30.4K ﹤0.01% 1968
2023
Q1 		– Sell
-37,180
Closed -$387K – 1909
2022
Q4 		$387K Hold
37,180
– – 0.01% 856
2022
Q3 		$379K Hold
37,180
– – 0.01% 970
2022
Q2 		$377K Buy
37,180
+2,985
+9% +$30.2K 0.01% 1048
2022
Q1 		$345K Buy
+34,195
New +$343K 0.01% 1126

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Centiva Capital's OCEA Position: Q3 2024 in Review

Centiva Capital sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2024, closing a stake of 17,800 shares — an estimated $21.7K sold.

Centiva Capital first reported a position in OCEA in Q1 2022 and held it in 5 quarters. The position peaked at $387K in Q4 2022. 21 funds tracked by Wall St. Rank hold OCEA as of Q3 2024.

  • Centiva Capital reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Centiva Capital sold 17,800 Ocean Biomedical, Inc. Common Stock shares in Q3 2024, an estimated $21.7K.
  • Centiva Capital first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Centiva Capital's Ocean Biomedical, Inc. Common Stock position peaked at $387K in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2024.

Based on Centiva Capital's 13F filing for Q3 2024, filed 14 Nov 2024.